Concepedia

Kang Le

KL

Statistics

Publications

6

Citations

253

H-Index

6

Active since

2011

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Kang Le is an author at The University of Texas MD Anderson Cancer Center specializing in cell biology, cell signaling, and medicine.

ORCID

Top concepts

Publications per year

2011–2024

6

Publications

6

Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties

Michael Soth, Kang Le, Maria Emilia Di Francesco et al. · Journal of Medicinal Chemistry · 2020 · 88 citations · Full text

The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways

Donna Badgwell, Zhimin Lu, Kang Le et al. · Oncogene · 2011 · 85 citations

, , +9

Inhibition of dual leucine zipper kinase prevents chemotherapy-induced peripheral neuropathy and cognitive impairments

Jiacheng Ma, Sunil Goodwani, Paul Acton et al. · Pain · 2021 · 28 citations · Full text

Dual Leucine Zipper Kinase Is Constitutively Active in the Adult Mouse Brain and Has Both Stress-Induced and Homeostatic Functions

Sunil Goodwani, Celia Fernandez, Paul Acton et al. · International Journal of Molecular Sciences · 2020 · 20 citations · Full text

, , +18

Discovery of IACS-52825, a Potent and Selective DLK Inhibitor for Treatment of Chemotherapy-Induced Peripheral Neuropathy

Kang Le, Michael Soth, Jason B. Cross et al. · Journal of Medicinal Chemistry · 2023 · 20 citations · Full text

1–5 of 6